welcome page

Our Story

1

The big problem

Cancer has a way of finding our loved ones and changing everything, once and for all.

2

3 people

Having lost people close to us to cancer, we came together at MIT to do something about it.

3

Understanding the problem

We began by understanding the problem through talking and conducting surveys.

4

Building a solution

We set off to build an intelligent treatment matching algrithm with a basic user interface.

5

Listening

We listened to feedback from patients and doctors.

6

Change is the only constant

We understand that treatments are constantly evolving. We need to keep up-to-date.

Our Service

Here is how it works.

Questions

Help us understand your condition by answering some questions about your diagnosis.

Treatments

Within a minute, our system of intelligent algorithms and veteran doctors present a list of treatments that fit your conditions best.

Consultation

Consult a doctor on our platform or in a clinic near you to decide on the treatment you should proceed with.

Launching in Q4 of 2019 with treatment recommendations for Pancreatic Cancer. Contact us to find out more.
Contact us

Meet our team

Optimistic, passionate, creative and non-conformist engineer with vast experience in Int. project management and a strong commitment to improve global healthcare.

A Healthcare enthusiast who previously worked at Biocon and Time Inc India. With a Master’s in Biotechnology from Imperial College London, she has more than 5 years of experience in cancer related projects.

With an immutable passion to improve healthcare around the world through technology, Srivatsa is constantly seeking ways to integrate AI into healthcare.

Dr. Natalia Eres

Advisor (Precision Medicine)

Founder of 3 integrative oncology clinics, she is also one of the Scientific Global Coordinator in Mens Apertis Cancer Research, a platform created to develop preclinical and clinical trials in integrative oncology.

Joan Bigorra

Advisor (Health Innovation & Pharma)

Joan has a vast experience in R&D and Pharma Industry as Managing Director of the Fundació Clínic for Biomedical Research, General Manager of Novartis Pharma Spain, Medical Director and Head of R&D of Bayer, Boehringer Ingelheim and Sandoz Pharma.

Dr. Pere Gascon

Advisor (Oncology)

Professor at the University of Barcelona and coordinator of L’Oncologia Clinica and Coordinator Scientist of the Clinical Institute of Hemato-Oncological Diseases (ICMHO) of the Hospital Clinic de Barcelona.

Let's fight cancer together

If you are a healthcare institution, or cancer association, and you want to be part of this healthcare revolution, contact us to become a partner.

Connect with us